Laddar...
A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
Alzheimer’s disease (AD), the most common cause of age-dependent dementia, is one of the most significant healthcare problems worldwide. Aggravating this situation, drugs that are currently US Food and Drug Administration (FDA)-approved for AD treatment do not prevent or delay disease progression. T...
Sparad:
| I publikationen: | CNS Drugs |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330928/ https://ncbi.nlm.nih.gov/pubmed/30830576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00613-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|